Please wait...

Incruse ellipta

Generic Name: umeclidinium (ue ME kli DIN ee um)
Brand Names: Incruse Ellipta
Incruse Ellipta (umeclidinium) is used to treat airflow obstruction in people with COPD. Includes Incruse Ellipta side effects, interactions and indications.
  • Prescription Settings

Prices and coupons of Incruse ellipta

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code

Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Incruse Ellipta (umeclidinium) is an anticholinergic that works by relaxing muscles in the airways to improve breathing. Incruse Ellipta is used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease, including bronchitis and emphysema. Incruse Ellipta is for use only in people with COPD and should not be used to treat asthma. You should not use Incruse Ellipta if you are allergic to umeclidinium or have a severe allergy to milk proteins. Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack. Learn more

Incruse ellipta Side Effects

Incruse Ellipta Side Effects

Note: This document contains side effect information about umeclidinium. Some of the dosage forms listed on this page may not apply to the brand name Incruse Ellipta.

For the Consumer

Applies to umeclidinium: inhalation powder

Along with its needed effects, umeclidinium (the active ingredient contained in Incruse Ellipta) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking umeclidinium:

Less common

  • Bladder pain
  • bloody or cloudy urine
  • cough or hoarseness
  • difficulty with breathing
  • fainting
  • fast, pounding, or irregular heartbeat or pulse
  • fever or chills
  • loss of voice
  • lower back or side pain
  • painful or difficult urination
  • sore throat
  • unusual tiredness or weakness

Incidence not known

  • Blurred vision
  • decreased urination
  • difficulty in passing urine (dribbling)
  • eye pain or discomfort

Some side effects of umeclidinium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Acid or sour stomach
  • body aches or pain
  • depression
  • diarrhea
  • dizziness or lightheadedness
  • joint pain
  • nausea
  • rash
  • sensation of spinning
  • upper abdominal or stomach pain

For Healthcare Professionals

Applies to umeclidinium: inhalation powder


Common (1% to 10%): Tachycardia, hypertension, sinus tachycardia (greater than or equal to 1%)

Uncommon (0.1% to 1%): Atrial fibrillation, idioventricular rhythm, supraventricular tachycardia, supraventricular extrasystoles


Common (1% to 10%): Rash


Common (1% to 10%): Upper abdominal pain, toothache, dyspepsia (greater or equal to 1%), diarrhea (greater or equal to 1%), nausea (greater or equal to 1%)

Uncommon (0.1% to 1%): Constipation, dry mouth


Common (1% to 10%): Urinary tract infection

Frequency not reported: Worsening of urinary retention


Common (1% to 10%): Arthralgia, myalgia, back pain, neck pain (greater or equal to 1%), pain in extremity (greater or equal to 1%)

Nervous system

Common (1% to 10%): Headache, sinus headache (greater or equal to 1%), dizziness (greater or equal to 1%)

Uncommon (0.1% to 1%): Dysgeusia


Common (1% to 10%): Contusion, vertigo (greater or equal to 1%)


Common (1% to 10%): Depression (greater or equal to 1%)


Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection, viral respiratory tract infection, cough, sinusitis, pneumonia (greater than or equal to 1%), lower respiratory tract infection (greater than or equal to 1%), rhinitis (greater than or equal to 1%), oropharyngeal pain (greater than or equal to 1%)

Uncommon (0.1% to 1%): Pharyngitis


Frequency not reported: Worsening of narrow-angle glaucoma (eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Incruse Ellipta